Hoffman William's Form 4 filing
Inari Medical, Inc. (NARI) · filed Jan 19, 2023
- Accession no.
- 0001127602-23-001795
- Filed
- Jan 19, 2023
- Trade date
- Jan 17, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.68M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | Common Stock | SSaleDisposed | −1,690 | $64.54 | −$109,072.6 | 399,233 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −4,110 | $65.51 | −$269,246.1 | 395,123 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −15,186 | $66.67 | −$1,012,450.62 | 379,937 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −10,799 | $67.74 | −$731,524.26 | 369,138 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −3,215 | $68.16 | −$219,134.4 | 365,923 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −800 | $64.51 | −$51,608 | 365,123 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −1,900 | $65.57 | −$124,583 | 363,223 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −6,520 | $66.70 | −$434,884 | 356,703 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −4,935 | $67.83 | −$334,741.05 | 351,768 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −845 | $68.18 | −$57,612.1 | 350,923 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −500 | $64.86 | −$32,430 | 350,423 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −1,600 | $66.44 | −$106,304 | 348,823 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −1,500 | $67.10 | −$100,650 | 347,323 | Direct | |
| Jan 17, 2023 | Common Stock | SSaleDisposed | −1,400 | $68.04 | −$95,256 | 345,923 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.